Hendrik Van Poppel

Professor Dr. Hendrik Van Poppel is the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit (KU) Leuven. He graduated in General Surgery in 1980, in Urology in 1983 and joined the Academic Unit at KU Leuven after his postgraduate training in London, Barcelona, Copenhagen, Mainz and Rotterdam. He obtained a PhD in Medical Sciences in 1988, became a Fellow of the European Board of Urology in 1992, and a full Professor of Urology in 1993. Professor Van Poppel is a Board Member of the European Association of Urology (EAU), Chairman of the Educational Office of the EAU and Director of the European School of Urology. He is also a member of the American Association of Genito-Urinary Surgeons, Chairman of the Scientific Committee of Europa Uomo, and Faculty Member of the European Society of Medical Oncology. In addition to that, he is a member of the most prominent urological societies worldwide. Professor Van Poppel has published more than 250 papers as first author and has co-authored more than 270 additional publications on urologic oncology. He is a reviewer for all major urological journals.

1books edited

Latest work with IntechOpen by Hendrik Van Poppel

Surgical and medical oncologists have been unable to decrease renal cell carcinoma mortality for uncertain reasons, although a lot of progress has been made in diagnosis and imaging, recognition of different genetic and pathological entities, management of localized disease and in the research on new drug treatments for advanced stages of the disease, potentially combined with surgery. The purpose of this book, which tackles a number of separate interesting topics, is to provide further insight into the disease and the management of early and advanced renal cell carcinoma. The volume is divided into different parts; the first part covers the characterization of renal masses and the second part covers rare distinct pathological entity. In the management section, active surveillance, partial nephrectomy and radiofrequency ablation are presented. A separate chapter reviews the management of Von Hippel Lindau disease, and finally, conventional and aberrant signaling pathways are explored.

Go to the book